Project Grant R56DK138666
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$223K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $539,220 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Pennington Biomedical Research Center. The grant supports research to examine the contribution of rapid nutrient delivery to gut-brain axis signaling in obesity and bariatric surgery. Key objectives include: 1) testing the hypothesis that rapid nutrient delivery is associated with...
This Project Grant award, valued at $689,050 and awarded on July 15, 2024 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research, supports research to define the roles of Gli1 periportal mesenchyme and epithelial Ihh in regulating epithelial-periportal mesenchymal crosstalk during intrahepatic bile duct (IHBD) development. The project aims to enhance understanding of the mechanisms...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $640,762 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The 5-year grant, effective September 15, 2024, supports research to define the communication network between the intestine and white adipose tissue that regulates metabolic homeostasis and contributes to obesity. Key objectives include: Establishing the interorgan...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to leverage glycan-metabolite interactions to shape the structure and function of the gut microbiome. The $1,970,885 award to The Children's Hospital Corporation (doing business as Boston Children's Hospital) will fund research that seeks to: 1) Define the impact of butyrate, a critical gut...
This $639,190 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research at Emory University to advance the understanding of the role of the apical sodium-dependent bile acid (BA) transporter (ASBT) in the pathogenesis of cholestatic liver disease and associated kidney injury. The key objectives of this 5-year research project are to: 1)...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $645,574 to Syntis Bio Inc. to develop an oral pill that mimics the effects of gastric bypass surgery. The goal is to create a once-daily oral medication that can block nutrient absorption in the duodenum, thereby achieving weight loss results similar to gastric bypass surgery. The...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $418,560 to evaluate the therapeutic potential of a new orally active small molecule compound for treating obesity-linked diabetes. The key objectives are to: 1) analyze the pharmacokinetic profiles and efficacy of the new compound in improving pancreatic islet cell function and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $1,170,271 to Northwestern University to conduct research on the unfolded protein response and bile acid metabolism. The central hypothesis is that the hepatic X-box binding protein 1 (XBP1) pathway regulates bile acid synthesis and metabolism during cholestatic liver disease. The...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Duke University a $241,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, effective July 25, 2024 through June 30, 2025, supports research to determine the mechanism by which a novel human gut bacterium, Clostridium immunis, and its exopolysaccharide (EPS) reduce visceral adiposity and protect against metabolic diseases. The research aims to...
This Project Grant award of $2,061,249.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research, will support research to identify and characterize microbial-derived "xenolipids" and their impact on host metabolic health. The project aims to leverage diverse human gut bacterial cultures to expand the catalog of microbial metabolites, and screen them for binding and bioactivity...